BIP Capital Partners

Skip to content

HOME
About us
- OUR TEAM
- OUR HISTORY
- ESG
- BIP IV
investment approach
- INVESTMENT APPROACH
- INVESTMENT CHARACTERISTICS
portfolio
- SELECTED INVESTMENTS
- SELECTED EXITS
News
CONTACT

BIP exits ENZYMOTEC: originally a private equity investment, quoted on the NASDAQ in 2013

Post navigation

Previous PostBIP invests in simpleshow, an explainer video pioneer Next PostBIP announces the sale of its investment in lifebrain

© BIP Group Luxembourg 2025

Stay in touch with us, leave your email